Icahn School of Medicine at Mount Sinai-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Droplet-based bisulfite sequencing for high-throughput profiling of single-cell DNA methylomes

    Nature communications, Vol. 14, Núm. 1, pp. 4672

2017

  1. Antipsychotic-induced Hdac2 transcription via NF-ΰ B leads to synaptic and cognitive side effects

    Nature Neuroscience, Vol. 20, Núm. 9, pp. 1247-1259

2016

  1. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

    Science Signaling, Vol. 9, Núm. 410

2014

  1. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

    Neuropharmacology, Vol. 86, pp. 311-318

2013

  1. Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

    European Neuropsychopharmacology, Vol. 23, Núm. 8, pp. 852-864

2012

  1. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

    Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254

  2. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function

    Journal of Biological Chemistry, Vol. 287, Núm. 53, pp. 44301-44319

2010

  1. α2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims

    Biological Psychiatry, Vol. 68, Núm. 9, pp. 869-872

2008

  1. Identification of a serotonin/glutamate receptor complex implicated in psychosis

    Nature, Vol. 452, Núm. 7183, pp. 93-97

2006

  1. Heterotrimeric G proteins: Insights into the neurobiology of mood disorders

    Current Neuropharmacology, Vol. 4, Núm. 2, pp. 127-138

2002

  1. Quantitative stoichiometry of G-proteins activated by μ-opioid receptors in postmortem human brain

    European Journal of Pharmacology, Vol. 452, Núm. 1, pp. 21-33